{
    "organizations": [],
    "uuid": "bbc8774726b8f53d3b6b66bd3a46fa2308734db2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-immuno-biological-laboratories-sig/brief-immuno-biological-laboratories-signs-ssea-3-antibody-related-sales-license-agreement-idUSL4N1QA0VB",
    "ord_in_thread": 0,
    "title": "BRIEF-Immuno-Biological Laboratories signs SSEA-3 antibody related sales license agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Immuno-Biological Laboratories Co Ltd\n* Says it signed sales license agreement with Life Science Institute, Inc., to sell SSEA-3 antibody to universities and pharmaceutical companies\nSource text in Japanese: goo.gl/mQqzYP\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-20T11:32:00.000+02:00",
    "crawled": "2018-02-20T14:11:58.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "laboratory",
        "co",
        "ltd",
        "say",
        "signed",
        "sale",
        "license",
        "agreement",
        "life",
        "science",
        "institute",
        "sell",
        "antibody",
        "university",
        "pharmaceutical",
        "company",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}